4/25/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guideline E11A

4/25/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines Q2(R...

4/22/2022U.S. SEC Adds BeyondSpring and Jrsis Healthcare to the Provisional Lis...

4/22/2022Bayer Seeks Expanded Use of Prostate Cancer Drug Nubeqa in China

4/22/2022Drug R&D and Product Registration News Digest April 2022 (3)

4/22/2022Recent Executive Moves

4/22/2022China's New Regulations on Human Genetic Resources Set to Speed Up R&D...

4/21/2022CDE Solicits Comments on Two Draft Documents on Pediatric Drug Informa...

4/21/2022CDE Issues the Technical Guidelines for Adverse Drug Reaction Data Sum...

4/21/2022ATUM Accelerates Entry of Bioengineering Solutions into China

4/21/2022Legend Makes $50M Milestone under J&J Partnership Deal for Anticancer...

4/20/2022Chugai Pharma Loses China's First Drug Patent Linkage Lawsuit

4/20/2022Roche Partners with Teva to Improve Lymphoma Treatments in China

4/20/2022Joseph Romanelli Returns to Merck to Lead Human Health International A...

4/20/2022I-Mab Reportedly Weighing Options Including Sale: Bloomberg

4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022

4/20/2022China Commercial Health Insurance Opportunities

4/19/2022NMPA Withdraws Approvals of 223 Domestic and Foreign Drug Products

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/18/2022Senior Health Official under Investigation for Corruption

4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...

4/18/2022CDE Solicits Comments on the Draft Technical Guidelines for Drug Clini...

4/18/2022BioBAY Suzhou - China's Biotechnology Megahub

4/17/2022666 White-listed Manufacturing Enterprises Including Nearly 100 Pharma...

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections

4/15/2022Drug R&D and Product Registration News Digest April 2022 (2)

4/14/2022Lenz and Ji Xing Announce an Exclusive Greater China License Agreement

4/14/2022Bayer Receives Chinese Approval for Its Cancer Drug Vitrakvi (larotrec...

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

Page:87/719 Total number of articles:21546: [First][<<] [85] [86] [87] [88] [89] [>>] [End]